383 related articles for article (PubMed ID: 25778452)
21. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
[TBL] [Abstract][Full Text] [Related]
22. siRNA-TMEM98 inhibits the invasion and migration of lung cancer cells.
Mao M; Chen J; Li X; Wu Z
Int J Clin Exp Pathol; 2015; 8(12):15661-9. PubMed ID: 26884835
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
Ji T; Zhang X; Li W
Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
25. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways.
Chang JH; Lai SL; Chen WS; Hung WY; Chow JM; Hsiao M; Lee WJ; Chien MH
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1746-1758. PubMed ID: 28648644
[TBL] [Abstract][Full Text] [Related]
26. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
27. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo.
Li D; Jin Y; Sun Y; Lei J; Liu C
Int J Oncol; 2014 Aug; 45(2):813-21. PubMed ID: 24889928
[TBL] [Abstract][Full Text] [Related]
29. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
[TBL] [Abstract][Full Text] [Related]
30. ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.
Kossmann CM; Annereau M; Thomas-Schoemann A; Nicco-Overney C; Chéreau C; Batteux F; Alexandre J; Lemare F
Tumour Biol; 2017 Jul; 39(7):1010428317716077. PubMed ID: 28675123
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro.
Fang Y; Guan X; Cai T; Long J; Wang H; Xie X; Zhang Y
Mol Med Rep; 2016 May; 13(5):3858-66. PubMed ID: 27035116
[TBL] [Abstract][Full Text] [Related]
33. In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.
Liu CM; Hsieh CL; He YC; Lo SJ; Liang JA; Hsieh TF; Josson S; Chung LW; Hung MC; Sung SY
PLoS One; 2013; 8(1):e53795. PubMed ID: 23342005
[TBL] [Abstract][Full Text] [Related]
34. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
[TBL] [Abstract][Full Text] [Related]
35. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
Sun BS; You J; Li Y; Zhang ZF; Wang CL
Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
[TBL] [Abstract][Full Text] [Related]
37. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8893-8901. PubMed ID: 32964979
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.
Li Y; Ma C; Qian M; Wen Z; Jing H; Qian D
Oncol Rep; 2014 Mar; 31(3):1271-6. PubMed ID: 24452698
[TBL] [Abstract][Full Text] [Related]
39. [Construction and identification of lentiviral vector of siRNA specific for Beclin1 gene].
Wang W; Zhao G; Zhou Y; Fan H; Wu G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Feb; 30(1):131-5. PubMed ID: 23488153
[TBL] [Abstract][Full Text] [Related]
40. [Construction of lentiviral mediated CyPA siRNA and its functions in non-small cell lung cancer].
FENG YM; WU YM; TU XM; XU ZS; WU WD
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Feb; 28(2):87-91. PubMed ID: 20450794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
